Quantcast
Last updated on April 17, 2014 at 11:16 EDT

Latest Antimalarial medication Stories

2014-03-19 23:01:16

The Deki Reader’s objective analysis of rapid diagnostic tests allows health workers of all skill levels to deliver results with a high degree of accuracy. Toronto, Ontario (PRWEB) March 19, 2014 A field evaluation recently published in Malaria Journal demonstrated consistent interpretation of rapid diagnostic tests (RDTs) for multiple disease strains between Fio Corporation’s Deki Reader™ and laboratory experts. The field evaluation analyzed results from 1,807 cases tested with an...

Climate Change Allows Malaria To Reach New Heights
2014-03-07 05:27:57

redOrbit Staff & Wire Reports - Your Universe Online Scientists from the London School of Hygiene & Tropical Medicine and the University of Michigan have discovered the first concrete evidence that the mosquito-borne disease malaria travels to higher elevations during warmer years and returns to lower altitudes when temperatures become cooler. In research appearing in the March 7 edition of Science, the study authors reviewed records from the highland regions of Colombia and...

2014-01-29 11:08:56

School-based intermittent screening and treatment programs for malaria may be unsuccessful in low to moderate transmission areas A school-based intermittent screening and treatment program for malaria in rural coastal Kenya had no benefits on the health and education of school children, according to a study by international researchers published in this week's PLOS Medicine. The study, led by Katherine Halliday and Simon Brooker from the London School of Hygiene & Tropical Medicine,...

2014-01-22 11:47:15

‘Dihydroartemisinin-piperaquine is more effective than artemether-lumefantrine, and has fewer side effects than artesunate-mefloquine’ concludes a systematic review published by the Cochrane Infectious Disease Group, hosted by LSTM. Dihydroartemisinin-piperaquine is one of five artemisinin-based combination therapies currently recommended by the World Health Organization (WHO), and this review finds that it is also one of the most studied. The team of authors from South Africa, Kenya,...

2013-12-23 11:07:23

Scientists have taken an important step towards new malaria treatments by identifying a way to stop malaria parasites from multiplying. In a study published in Nature Chemistry, they show that blocking the activity of an enzyme called NMT in the most common malaria parasite prevents mice from showing symptoms and extends their lifespan. The team are working to design molecules that target NMT more potently, and hope to start clinical trials of potential treatments within four years. A...

2013-12-04 10:38:28

An analysis of patients from across the malaria endemic world suggests that a key antimalarial treatment could be improved by better dosing in young children Antimalarial drug resistance has hampered malaria control programs for almost 60 years. A key factor in combatting this threat is to ensure that all antimalarial drugs are deployed in a way that ensures that the maximum number of patients are completely cured. A study published this week in PLOS Medicine explores this issue by...

Possible New Weapon Identified To Attack Parasites That CAuse Malaria
2013-11-27 17:08:48

University of California - San Diego Using advanced methodologies that pit drug compounds against specific types of malaria parasite cells, an international team of scientists, including researchers at the University of California, San Diego School of Medicine and the Genomics Institute of the Novartis Research Foundation, have identified a potential new weapon and approach for attacking the parasites that cause malaria. Their findings are published in the November 27, 2013 advanced...

2013-11-14 13:04:52

Lower doses of the antimalarial drug primaquine are as effective as higher doses in reducing malaria transmission, according to a study published today in Lancet Infectious Diseases by London School of Hygiene & Tropical Medicine researchers. Primaquine is one of the few antimalarial drugs that targets the transmission stages of the malaria parasite, the gametocytes, and is therefore considered to be an important tool for malaria elimination. However, standard doses of the drug...

2013-11-14 12:45:34

Partners agree on approach for developing vaccines capable of reducing malaria cases by 75 percent, and to enable malaria elimination The world should aim to have vaccines which reduce malaria cases by 75 percent, and are capable of eliminating malaria, licensed by 2030, according to the updated 2013 Malaria Vaccine Technology Roadmap, launched today. This new target comes in addition to the original 2006 Roadmap's goal of having a licensed vaccine against Plasmodium falciparum malaria,...

2013-11-07 20:21:58

TOKYO and NEW YORK, Nov. 7, 2013 /PRNewswire-USNewswire/ -- The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease. "Our six new investments in potential treatments for malaria, tuberculosis and...